Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States
Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States have?
Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States published?
Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States has 2021 year in the ScholarIQ index.
What is the open-access status of Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States?
Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States has gold oa status in the ScholarIQ index.
What is the DOI of Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States?
The DOI for Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States is on the source record.
What is the OpenAlex record for Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States?
The OpenAlex for Benefit of Prompt Versus Delayed Initiation of Single Inhaler Triple Therapy on Exacerbations and Healthcare Costs Among Patients with Chronic Obstructive Pulmonary Disease in the United States is on the source record.